Orca Surgical develops pioneering solutions for ophthalmologic surgery, focused on the cornea. The company is committed to innovating and bringing to market devices and technologies for refractive surgery, keratoconus, refractive enhancement, and treatments for recurrent erosion of the cornea. The medical device EpiClear™ is FDA approved Class I Exempt in the US, CE Marked in Europe and AMAR approved in Israel and fully patented all over the world. Orca Surgical is certified for ISO 13485. A privately owned company, backed by a seasoned multidisciplinary team of professionals and researchers. Our headquarters are located in Israel, with distributors in the US, Europe and Asia. The scientific advisory board includes Prof. Marguerite McDonald and Dr. William B. Trattler, from the U.S. and Prof. Jose Luis Guell, from Spain. For more information (as well as a demonstration kit) please contact us by email at: info@orcasurgical.com. Visit our website for testimonials and more information